Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity

Digestive Diseases and Sciences

Volumn 54, Issue 8, 2009, Pages 1643-1650

  You, Yu ^a   Fu, Jian Jiang ^b   Meng, Jun ^c   Huang, Guo Dong ^a   Liu, Yu Hui ^b  

^a NANCHANG UNIVERSITY   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c JIANGXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Colitis; N acetylcysteine; Paraoxonase1; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ARYLDIALKYLPHOSPHATASE 1; DEXTRAN SULFATE; DRINKING WATER; ENEMA; FREE RADICAL; GLUTATHIONE; INTERLEUKIN 1BETA; MALONALDEHYDE; MESALAZINE; MYELOPEROXIDASE; PLACEBO; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOODY DIARRHEA; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; UPREGULATION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; COLON; DISEASE MODEL; DOWN REGULATION; HOSPITALIZATION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLUTATHIONE; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PEROXIDASE; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 67649998225     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0563-9     Document Type: Article

References (34)

1. W Strober PJ Murray A Kitani 2006 Signalling pathways and molecular interactions of NOD1 and NOD2 Nat Rev Immunol 6 9 20 10.1038/nri1747
2. MG Netea BJ Kullberg DJ de Jong 2004 NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease Eur J Immunol 34 2052 2059 10.1002/eji.200425229
3. JE Mawdsley DG Jenkins MG Macey 2008 The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis Am J Gastroenterol 103 6 1460 1469 10.1111/j.1572-0241.2008.01845.x
4. HS Lee SY Han EA Bae 2008 Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice Int Immunopharmacol 8 4 574 580 10.1016/j.intimp.2008.01.009
5. R Rahimi S Nikfar M Abdollahi 2007 Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids Med Sci Monit 13 7 PI13 PI18
6. R Rahimi S Nikfar Mohammad Abdollahi 2007 Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials Biomed Pharmacother 61 1 75 80 10.1016/j.biopha.2006.06.022
7. R Rahimi S Nikfar A Rezaie 2006 A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn's disease Clin Ther 28 1983 1988 10.1016/j.clinthera.2006.12.012
8. R Rahimi S Nikfar A Rezaie 2007 A meta-analysis of antibiotic therapy for active ulcerative colitis Dig Dis Sci 52 11 2920 2925 10.1007/s10620-007-9760-1
9. TS Helieh Oza S Theresa Chenb J Craig McClain 2005 Antioxidants as novel therapy in a murine model of colitis J Nutr Biochem 16 297 304 10.1016/j.jnutbio.2004.09.007
10. Y Isozaki N Yoshida M Kuroda 2006 Effect of a novel water-soluble vitamin E derivative as a cure for TNBS-induced colitis in rats Int J Mol Med 17 3 497 502
11. L Kruidenier I Kuiper CB Lamers 2003 Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants J Pathol 201 1 28 36 10.1002/path.1409
12. J Mrtensson A Jain A Meister 1990 Glutathione is required for intestinal function Proc Natl Acad Sci USA 87 1715 1719 10.1073/pnas.87.5.1715
13. MS Soltan-Sharifi M Mojtahedzadeh A Najafi 2007 Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms Hum Exp Toxicol 26 9 697 703 10.1177/0960327107083452
14. F Ebrahimi H Esmaily M Baeeri 2008 Molecular evidences on the benefit of N-acetylcysteine in experimental colitis Cent Eur J Biol 3 2 135 142 10.2478/s11535-008-0005-x
15. PN Durrington B Mackness MI Mackness 2001 Paraoxonase and atherosclerosis Arterioscler Thromb Vasc Biol 21 473 480 (Pubitemid 32323376)
16. G Baskol M Baskol A Yurci 2006 Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis Cell Biochem Funct 24 3 283 286 10.1002/cbf.1224
17. L Rothem C Hartman A Dahan 2007 Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum Free Radic Biol Med 43 730 739 10.1016/j.freeradbiomed. 2007.05.003
18. O Kanauchi T Nakamura K Agata 1998 Effects of germinated barley food stuff on dextran sulfate sodium-induced colitis in rats J Gastroenterol 33 179 188 10.1007/s005350050067
19. LM Sanders CE Henderson MY Hong 2004 Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility Cancer Lett 208 155 161 10.1016/j.canlet.2003.12.007
20. K Suzuki K Sugimura K Hasegawa 2001 Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes Scand J Gastroenterol 36 1301 1306 10.1080/003655201317097164
21. JE Qualls AM Kaplan N van Rooijen 2006 Suppression of experimental colitis by intestinal mononuclear phagocytes J Leukoc Biol 80 4 802 815 10.1189/jlb.1205734
22. A Rezaie RD Parker M Abdollahi 2007 Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 52 9 2015 2021 10.1007/s10620-006-9622-2
23. A Banan S Choudhary Y Zhang 2000 Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton Free Radic Biol Med 28 5 727 738 10.1016/S0891-5849(00)00160-X
24. L Kruidenier I Kuiper W Van Duijn 2003 Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease J Pathol 201 1 17 27 10.1002/path.1408
25. TY Aw 2005 Intestinal glutathione: determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility Toxicol Appl Pharmacol 204 3 320 328 10.1016/j.taap.2004.11.016
26. M Aviram S Billecke R Sorenson 1998 Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different than that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R Arterioscler Thromb Vasc Biol 18 1617 1624 (Pubitemid 28465415)
27. M Aviram M Rosenblat S Billecke 1999 Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants Free Radic Biol Med 26 892 904 (Pubitemid 29198362)
28. Y-H Liu L-Y Liu J-X Wu 2006 Comparison of Captopril and Enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice J Cardiovasc Pharmacol 47 1 82 88 (Pubitemid 44378229)
29. V Nosal'ova S Cerna V Bauer 2000 Effect of N-acetylcysteine on colitis induced by acetic acid in rats Gen.Pharmaco 35 2 77 81 (Pubitemid 33052466)
30. RC Scarpulla 2002 Nuclear activators and coactivators in mammalian mitochondrial biogenesis Biochim Biophys Acta 1576 1 14 (Pubitemid 34597079)
31. PJ Barnes M Karin 1997 Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1066 1071 (Pubitemid 27163860)
32. Y Kumon Y Nakauchi T Suehiro 2002 Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by Hep G2 Amyloid 9 160 164 (Pubitemid 35205205)
33. AM Chromik AM Müller M Albrecht 2007 Oral administration of taurolidine ameliorates chronic DSS colitis in mice J Invest Surg 20 5 273 282 (Pubitemid 350048043)
34. M Paganelli C Albanese O Borrelli 2007 Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease Inflamm Bowel Dis 13 4 416 423 (Pubitemid 46668246)